Intrahepatic biliary-intestinal bypass in malignant jaundice

Area of Science:

• Hepatobiliary Surgery
• Surgical Oncology
• Gastroenterology

Background:

• Malignant obstructive jaundice presents treatment challenges, particularly with high bile duct blockages.
• Surgical bypass, specifically intrahepatic duct-to-jejunal anastomoses, offers an alternative to external appliances.

Purpose of the Study:

• To evaluate the efficacy and outcomes of intrahepatic duct-to-jejunal anastomoses in patients with malignant obstructive jaundice.
• To assess bilirubin clearance, jaundice recurrence, hospital stay, operative mortality, and survival rates.

Main Methods:

• A retrospective study of eight patients undergoing intrahepatic duct-to-jejunal bypass for malignant obstructive jaundice.
• Analysis of postoperative bilirubin levels, duration of jaundice relief, hospital length of stay, and patient survival.

Main Results:

• Bilirubin clearance was achieved within the lower normal range.
• Jaundice relief persisted until death, with a median survival of 5 months post-surgery.
• No postoperative cholangitis occurred, and operative mortality was low (one patient).
• The median hospital stay was 30 days, identified as a major disadvantage.

Conclusions:

• Intrahepatic duct-to-jejunal bypass is an effective surgical option for malignant obstructive jaundice, offering durable palliation.
• The prolonged hospital stay necessitates consideration when comparing surgical bypass with less invasive endoscopic or percutaneous methods.